It has been shown that CSF interleukin (IL)-6 is increased in neuromyelitis optica spectrum disorders (NMOSD) or in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) compared to MS (17). The gene discussed is MOG; the disease is neuromyelitis optica.